BioVitesse provides the fast growing
industrial microbiological control market with automated
in-process monitoring systems to detect and identify
bacterial contamination, inside the clean rooms, in less
than 4 hours instead of days. The company will first address
Biopharmaceutical facilities followed by Pharmaceutical and
food safety segments. The systems are enabled by a highly
innovative micro-fluidic silicon biochip and with an-off
chip concentration and recovery technologies. Rapid
detection drastically reduces discarded material; Clean room
testing eliminates the risk of sample contamination. The
company is funded by NSF, the State of Indiana, Angel
investors, and its founders.
